Airway smooth muscle malfunction in COPD

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Airway smooth muscle has been conventionally regarded as a contractile partner in bronchoconstriction. It also interacts dynamically with its environment, especially under inflammatory conditions, modulates the pathological processes in the development of chronic obstructive pulmonary disease (COPD). Airway smooth muscle cells are able to proliferate, to secrete cytokines, growth factors, prostanoid, and extracellular matrix proteins, and to adapt to these functions by changing its phenotype from contractile to synthetic. In COPD, smooth muscle in the small airways exhibit hyperresponsiveness and higher contractility in calcium-dependent and -independent mechanisms. Airway smooth muscle cell hyperplasia and hypertrophy as well as increased deposition of extracellular matrix (ECM) proteins contribute to airway remodeling and thickening. Many inflammatory mediators and growth factors, including interleukins, tumor necrosis factor-α (TNF-α), leukotrienes, prostaglandins, acetylcholine, platelet-derived growth factor (PDGF), transform growth factor β (TGFβ), connective tissue growth factor (CTGF), endothelin, and reactive oxygen species (ROS), contribute to the alterations of airway smooth muscle in COPD. Investigating the mechanism and regulatory pathways of airway smooth muscle malfunction may provide novel options for the prevention and treatment for airflow obstruction in COPD.

Original languageEnglish (US)
Title of host publicationCalcium Signaling In Airway Smooth Muscle Cells
PublisherSpringer International Publishing
Pages441-457
Number of pages17
Volume9783319013121
ISBN (Electronic)9783319013121
ISBN (Print)3319013114, 9783319013114
DOIs
StatePublished - Nov 1 2014

Fingerprint

Pulmonary diseases
Chronic Obstructive Pulmonary Disease
Smooth Muscle
Muscle
Intercellular Signaling Peptides and Proteins
Extracellular Matrix Proteins
Prostaglandins
Smooth Muscle Myocytes
Connective Tissue Growth Factor
Airway Remodeling
Bronchoconstriction
Leukotrienes
Interleukins
Platelet-Derived Growth Factor
Endothelins
Pathologic Processes
Hypertrophy
Acetylcholine
Hyperplasia
Reactive Oxygen Species

Keywords

  • Airway
  • Bronchoconstriction
  • Inflammation
  • Remodeling
  • Smooth muscle

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Su, Y. (2014). Airway smooth muscle malfunction in COPD. In Calcium Signaling In Airway Smooth Muscle Cells (Vol. 9783319013121, pp. 441-457). Springer International Publishing. https://doi.org/10.1007/978-3-319-01312-1_25

Airway smooth muscle malfunction in COPD. / Su, Yunchao.

Calcium Signaling In Airway Smooth Muscle Cells. Vol. 9783319013121 Springer International Publishing, 2014. p. 441-457.

Research output: Chapter in Book/Report/Conference proceedingChapter

Su, Y 2014, Airway smooth muscle malfunction in COPD. in Calcium Signaling In Airway Smooth Muscle Cells. vol. 9783319013121, Springer International Publishing, pp. 441-457. https://doi.org/10.1007/978-3-319-01312-1_25
Su Y. Airway smooth muscle malfunction in COPD. In Calcium Signaling In Airway Smooth Muscle Cells. Vol. 9783319013121. Springer International Publishing. 2014. p. 441-457 https://doi.org/10.1007/978-3-319-01312-1_25
Su, Yunchao. / Airway smooth muscle malfunction in COPD. Calcium Signaling In Airway Smooth Muscle Cells. Vol. 9783319013121 Springer International Publishing, 2014. pp. 441-457
@inbook{2926e51973364d0f8738f3b8d85147e8,
title = "Airway smooth muscle malfunction in COPD",
abstract = "Airway smooth muscle has been conventionally regarded as a contractile partner in bronchoconstriction. It also interacts dynamically with its environment, especially under inflammatory conditions, modulates the pathological processes in the development of chronic obstructive pulmonary disease (COPD). Airway smooth muscle cells are able to proliferate, to secrete cytokines, growth factors, prostanoid, and extracellular matrix proteins, and to adapt to these functions by changing its phenotype from contractile to synthetic. In COPD, smooth muscle in the small airways exhibit hyperresponsiveness and higher contractility in calcium-dependent and -independent mechanisms. Airway smooth muscle cell hyperplasia and hypertrophy as well as increased deposition of extracellular matrix (ECM) proteins contribute to airway remodeling and thickening. Many inflammatory mediators and growth factors, including interleukins, tumor necrosis factor-α (TNF-α), leukotrienes, prostaglandins, acetylcholine, platelet-derived growth factor (PDGF), transform growth factor β (TGFβ), connective tissue growth factor (CTGF), endothelin, and reactive oxygen species (ROS), contribute to the alterations of airway smooth muscle in COPD. Investigating the mechanism and regulatory pathways of airway smooth muscle malfunction may provide novel options for the prevention and treatment for airflow obstruction in COPD.",
keywords = "Airway, Bronchoconstriction, Inflammation, Remodeling, Smooth muscle",
author = "Yunchao Su",
year = "2014",
month = "11",
day = "1",
doi = "10.1007/978-3-319-01312-1_25",
language = "English (US)",
isbn = "3319013114",
volume = "9783319013121",
pages = "441--457",
booktitle = "Calcium Signaling In Airway Smooth Muscle Cells",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Airway smooth muscle malfunction in COPD

AU - Su, Yunchao

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Airway smooth muscle has been conventionally regarded as a contractile partner in bronchoconstriction. It also interacts dynamically with its environment, especially under inflammatory conditions, modulates the pathological processes in the development of chronic obstructive pulmonary disease (COPD). Airway smooth muscle cells are able to proliferate, to secrete cytokines, growth factors, prostanoid, and extracellular matrix proteins, and to adapt to these functions by changing its phenotype from contractile to synthetic. In COPD, smooth muscle in the small airways exhibit hyperresponsiveness and higher contractility in calcium-dependent and -independent mechanisms. Airway smooth muscle cell hyperplasia and hypertrophy as well as increased deposition of extracellular matrix (ECM) proteins contribute to airway remodeling and thickening. Many inflammatory mediators and growth factors, including interleukins, tumor necrosis factor-α (TNF-α), leukotrienes, prostaglandins, acetylcholine, platelet-derived growth factor (PDGF), transform growth factor β (TGFβ), connective tissue growth factor (CTGF), endothelin, and reactive oxygen species (ROS), contribute to the alterations of airway smooth muscle in COPD. Investigating the mechanism and regulatory pathways of airway smooth muscle malfunction may provide novel options for the prevention and treatment for airflow obstruction in COPD.

AB - Airway smooth muscle has been conventionally regarded as a contractile partner in bronchoconstriction. It also interacts dynamically with its environment, especially under inflammatory conditions, modulates the pathological processes in the development of chronic obstructive pulmonary disease (COPD). Airway smooth muscle cells are able to proliferate, to secrete cytokines, growth factors, prostanoid, and extracellular matrix proteins, and to adapt to these functions by changing its phenotype from contractile to synthetic. In COPD, smooth muscle in the small airways exhibit hyperresponsiveness and higher contractility in calcium-dependent and -independent mechanisms. Airway smooth muscle cell hyperplasia and hypertrophy as well as increased deposition of extracellular matrix (ECM) proteins contribute to airway remodeling and thickening. Many inflammatory mediators and growth factors, including interleukins, tumor necrosis factor-α (TNF-α), leukotrienes, prostaglandins, acetylcholine, platelet-derived growth factor (PDGF), transform growth factor β (TGFβ), connective tissue growth factor (CTGF), endothelin, and reactive oxygen species (ROS), contribute to the alterations of airway smooth muscle in COPD. Investigating the mechanism and regulatory pathways of airway smooth muscle malfunction may provide novel options for the prevention and treatment for airflow obstruction in COPD.

KW - Airway

KW - Bronchoconstriction

KW - Inflammation

KW - Remodeling

KW - Smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=84930021523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930021523&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-01312-1_25

DO - 10.1007/978-3-319-01312-1_25

M3 - Chapter

AN - SCOPUS:84930021523

SN - 3319013114

SN - 9783319013114

VL - 9783319013121

SP - 441

EP - 457

BT - Calcium Signaling In Airway Smooth Muscle Cells

PB - Springer International Publishing

ER -